Cognate BioServices closes Series B and completes acquisition ...
MEMPHIS, Tenn., Jan. 22, 2020 /PRNewswire-AsiaNet/ -- Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed the acquisition of Cobra Biologics, a leading CDMO speciali...
Authors: LATEST ASIANET NEWS RELEASES